TOBY Xenon Study
Neuroprotective effects of Hypothermia combined with inhaled xenon following perinatal asphyxia
This is a proof-of-concept study to test the hypothesis that following perinatal asphyxia treatment with a combination of hypothermia and inhaled xenon reduces cerebral biochemical abnormality, preserves cerebral structures, and leads to improved clinical outcomes at hospital discharge.
![](https://www.ucl.ac.uk/womens-health/sites/womens_health/files/styles/medium_image/public/clinical-magnet-group.jpg?itok=LA1nVsKn)
Neonatal Clinical Magnet Group
There are three London centres participating in this trial: University College Hospital, St Thomas’s Hospital, Queen Charlotte’s Hospital.
The team at UCL
- PI: Nicola Robertson
- Mary Dinan, Advanced neonatal neurology nurse practitioner
- Dr Giles Kendall, Consultant Neonatologist
- Dr Cristine Uria, Research Fellow (PhD student)
- Dr Alan Bainbridge, MR physicist
- Mr David Price, MR physicist
For more information on the TOBY Xe trial:
www.npeu.ox.ac.uk/toby-xe
References
Azzopardi D, Robertson NJ, Kapetanakis A, Griffiths J, Rennie JM, Mathieson SR, Edwards AD. Anticonvulsant effect of xenon on neonatal asphyxial seizures. Arch Dis Child Fetal Neonatal Ed. 2013 Apr 9.